Loading page content…
Loading page content…
| Source: | Contracts Finder |
| Notice Type: | Tender notice |
| Buyer: | Newcastle University |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £2,000,000 |
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
5 January 2023
Closed
Estimated Value
£2,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Release Date: |
| 24 November 2022 |
| Application Deadline: | 5 January 2023 |
| Procurement ID (OCID): | ocds-b5fd17-38625a87-b3f2-408f-a063-826408f8575f |
| Notice Reference: | 8fa99bfc-4661-4938-b5a6-bda9f7f1c443-593073 |
View Original Notice
Access the full notice on the official portal
The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the "NASH Disease Translational Accelerator" (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The purpose of this tender process is to engage a supplier to provide clinical research support, central laboratory services and to oversee biological sample transfers and provide centralised laboratory processing of biological samples collected during the course of the study.